GRF Grifols, S.A.

12.14USD11.07 EUR · BME-3.28%Mkt Cap: 8.26B USDP/E: 15.37

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates thr…